Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Paroxysmal Cold Hemoglobinuria Successfully Treated with Complement Inhibition

Sarah A Lau-Braunhut, MD, Hannah Stone, Griffin Collins, MD, Sigbjørn Berentsen, MD PhD, Matt Zinter, MD, Benjamin Braun, MD PhD

Blood (2019) 134 (Supplement_1): 4798.

https://doi.org/10.1182/blood-2019-126365

Published: 2019

Journal Articles

Type B Lactic Acidosis in Adults with Hemophagocytic Lymphohistiocytosis

Fares T. Rajah, MBBS, Abdullah S. S. Al Saleh, MBBS, Salih A. Bin Salih, MDFACP FRCP (Edin)

Blood (2019) 134 (Supplement_1): 4879.

https://doi.org/10.1182/blood-2019-121432

Published: 2019

Journal Articles

Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities

Andrea Papait, PhD, Tiziana Vaisitti, PhD, Sara Serra, PhD, Valentina Audrito, PhD, Francesco Tito, Giulia Guerra, Dimitar G Efremov, MDPhD, Silvia Deaglio, MD PhD

Blood (2018) 132 (Supplement 1): 240.

https://doi.org/10.1182/blood-2018-99-118057

Published: 2018

Journal Articles

Parenteral L-Arginine Improves Mitochondrial Function in Children with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Episodes

Sruti Shiva, PhD, Lou Ann Brown, PhD, Y Wang, Carlton Dampier, MD, Amanda Watt, Vinita Tripathi, Amina Bhutta, MD, Polly Kumari, MD, Janet Figueroa, MPH, April Zmitrovich, MSW, MPH, Claudia R. Morris, MD

Blood (2018) 132 (Supplement 1): 508.

https://doi.org/10.1182/blood-2018-99-112666

Published: 2018

Journal Articles

Congenital Methemoglobinemia Under Diagnosed Condition with Variiable Therapeurtic Options

Mohamed A. Yassin, MBBS,MSc,CABM,FACP,MSC, Dina Sameh Soliman, PhD

Blood (2017) 130 (Supplement 1): 4746.

https://doi.org/10.1182/blood.V130.Suppl_1.4746.4746

Published: 2017

Journal Articles

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Shahla Bari, MD, Marina Rabinovich, PharmD, BCPS, Marjorie Curry, PharmD, BCOP, Sanjay Raj Jain, MD PhD, Lorraine Cafuir, MD

Blood (2017) 130 (Supplement 1): 4926.

https://doi.org/10.1182/blood.V130.Suppl_1.4926.4926

Published: 2017

Journal Articles

Morphologic features of normoblasts in a case of myopathy, lactic acidosis, and sideroblastic anemia

Geling Li, Lee M. Hilliard

Blood (2017) 129 (8): 1057.

https://doi.org/10.1182/blood-2016-11-752717

Published: 2017

Journal Articles

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Zanetta S. Lamar, MD, Scott Isom, MS, Rakhee Vaidya, MD, Anne W Beaven, MD, Zachariah A. McIver, DO

Blood (2016) 128 (22): 4163.

https://doi.org/10.1182/blood.V128.22.4163.4163

Published: 2016

Journal Articles

Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and I n Vivo Efficacy Results

Dipanjan Pan, PhD, Stephen Rogers, PhD, Santosh Misra, PhD, Gururaja Vulugundam, PhD, Lisa Gazdzinski, MS, Albert Tsui, PhD, Nikhil Mistry, MS, Ahmed Said, MD PhD, Philip Spinella, MD, Greg Hare, MD PhD, Greg Lanza, MD PhD, Allan Doctor, MD

Blood (2016) 128 (22): 1027.

https://doi.org/10.1182/blood.V128.22.1027.1027

Published: 2016

Journal Articles

Type B Lactic Acidosis in Advanced Diffuse Large B-Cell Lymphoma

Nancy El-Shamaa Kaddis, MD MPH

Blood (2016) 128 (22): 5420.

https://doi.org/10.1182/blood.V128.22.5420.5420

Published: 2016

Journal Articles

A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma

Selina Dobing, MD BSc, Nikolas Desilet, MD BSc, Irwindeep Sandhu, MD, Lauren Bolster, MD MD FRCPC

Blood (2015) 126 (23): 4539.

https://doi.org/10.1182/blood.V126.23.4539.4539

Published: 2015

Journal Articles

Clinico-Pathological Features and Outcomes in Patients with Congenital Sideroblastic Anemias

Leah Ann Schmelkin, BS, Matthew T Howard, MD, David P. Steensma, MD, Mark D. Fleming, MD DPhil, Vilmarie Rodriguez, MD, Shakila Khan, MD, Naseema Gangat, MBBS, Alexandra Wolanskyj, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 3355.

https://doi.org/10.1182/blood.V126.23.3355.3355

Published: 2015

Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Amine Ale-Ali, PharmD, Thomas J. Kipps, MD, PhD

Blood (2015) 126 (23): 4160.

https://doi.org/10.1182/blood.V126.23.4160.4160

Published: 2015

Journal Articles

Tissue Oxygenation By Transfusion in Severe Anemia with Lactic Acidosis (TOTAL): A Prospective, Randomized, Non-Inferiority Trial of Blood Storage Duration

Aggrey Dhabangi, MD, Brenda Ainomugisha, MD, Christine M. Cserti-Gazdewich, MD, Henry Ddungu, MBCHB, M.MD(Int. MD, Dorothy Kyeyune, MD, Ezra Musisi, Robert Opoka, MD, Christopher P. Stowell, MD PhD, Walter H. Dzik, MD

Blood (2015) 126 (23): 769.

https://doi.org/10.1182/blood.V126.23.769.769

Published: 2015

Journal Articles

Obinutuzumab (GA101) in Combination with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) or Bendamustine for the First-Line Treatment of Follicular Non-Hodgkin Lymphoma: Final Results from the Maintenance Phase of the Phase Ib GAUDI Study

Martin JS Dyer, Andrew P Grigg, MBBS FRACP FRCPA MD, Marcos González Díaz, MD PhD, Martin Dreyling, Simon Rule, MD, Guiyuan Lei, PhD, Elisabeth Wassner-Fritsch, PharmD, Günter Fingerle-Rowson, MDPhD, Paula V Marlton, MBBS

Blood (2014) 124 (21): 1743.

https://doi.org/10.1182/blood.V124.21.1743.1743

Published: 2014

Journal Articles

EBV-driven HIV-associated diffuse large B-cell lymphoma causing profound lactic acidosis

Bonnie C. Prokesch, Michael U. Shiloh

Blood (2014) 124 (6): 842.

https://doi.org/10.1182/blood-2014-04-567743

Published: 2014

Journal Articles

MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study

Daniel J. DeAngelo, MD, Ph.D, Harry P Erba, MD, Michael B Maris, MD, Ronan T. Swords, MD, PhD, FRCPI, FRCPath, Faiz Anwer, MD, Jessica K Altman, MD, Zhaowei Hua, Ph.D, Stephen J Blakemore, Ph.D, Hélène Faessel, Ph.D, Bruce J Dezube, MD, Bruno C Medeiros, MD

Blood (2013) 122 (21): 1443.

https://doi.org/10.1182/blood.V122.21.1443.1443

Published: 2013

Journal Articles

Synergistic Antileukemic Effect Of Sequential Administration Of Dichloroacetate (DCA) Combined With Arsenic Trioxide (ATO) In Primary Blasts From Patients With Acute Myeloid Leukemia (AML) and FLT3-ITD AML Cell Lines

Ashkan Emadi, M.D., Ph.D., Brandon Carter-Cooper, BS, Mariola Sadowska, PhD, Omasiri Wonodi, BS, Rena G. Lapidus, PhD, Mark Levis, MD, PhD, Edward A. Sausville, MD, PhD

Blood (2013) 122 (21): 3955.

https://doi.org/10.1182/blood.V122.21.3955.3955

Published: 2013

Journal Articles

SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b

Cornelia Zeidler, MD, Kinan Kafa, Martin G. Sauer, MD, Britta Maecker-Kolhoff, Johann Greil, MD, Karl Welte, MD, Christian P Kratz, MD, Karl-Walter Sykora

Blood (2012) 120 (21): 4402.

https://doi.org/10.1182/blood.V120.21.4402.4402

Published: 2012

Journal Articles

ABO In Morbidity and Mortality of Plasmodium Falciparum malaria

Christine Cserti-Gazdewich, MD, FRCPC, Charles Musoke, MBChB, MMEd, (cand), Aggrey Dhabangi, MBChB, MMEd, (cand), Deborah Nakiboneka-Ssenabulya, MBChB, MMEd, Henry Ddungu, MD, Nicolette Nabukeera-Barungi, MBChB, MMEd, Arthur Mpimbaza, MBChB, MMEd, Isaac Ssewanyana, BSc, Walter H Dzik, MD

Blood (2010) 116 (21): 666.

https://doi.org/10.1182/blood.V116.21.666.666

Published: 2010

NARROW

Paroxysmal Cold Hemoglobinuria Successfully Treated with Complement Inhibition

Type B Lactic Acidosis in Adults with Hemophagocytic Lymphohistiocytosis

Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities

Parenteral L-Arginine Improves Mitochondrial Function in Children with Sickle Cell Disease Admitted for Vaso-Occlusive Pain Episodes

Congenital Methemoglobinemia Under Diagnosed Condition with Variiable Therapeurtic Options

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Morphologic features of normoblasts in a case of myopathy, lactic acidosis, and sideroblastic anemia

Phase I Dose-Escalation Study of Cpi-613, in Combination with Bendamustine, in Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and I n Vivo Efficacy Results

Type B Lactic Acidosis in Advanced Diffuse Large B-Cell Lymphoma

A Novel Case of Direct Antiglobulin Test-Negative Intravascular Hemolysis in a Patient with Smoldering Myeloma

Clinico-Pathological Features and Outcomes in Patients with Congenital Sideroblastic Anemias

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Tissue Oxygenation By Transfusion in Severe Anemia with Lactic Acidosis (TOTAL): A Prospective, Randomized, Non-Inferiority Trial of Blood Storage Duration

Obinutuzumab (GA101) in Combination with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) or Bendamustine for the First-Line Treatment of Follicular Non-Hodgkin Lymphoma: Final Results from the Maintenance Phase of the Phase Ib GAUDI Study

EBV-driven HIV-associated diffuse large B-cell lymphoma causing profound lactic acidosis

MLN4924, a Novel Investigational Inhibitor Of NEDD8-Activating Enzyme (NAE), In Adult Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Results From Multiple Dosing Schedules In a Phase 1 Study

Synergistic Antileukemic Effect Of Sequential Administration Of Dichloroacetate (DCA) Combined With Arsenic Trioxide (ATO) In Primary Blasts From Patients With Acute Myeloid Leukemia (AML) and FLT3-ITD AML Cell Lines

SCT for Secondary AML in a Patient with Glycogen Storage Disease Type 1b

ABO In Morbidity and Mortality of Plasmodium Falciparum malaria

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only